Stephen L. Rawlings

Array ( [id] => 1491209 [patent_doc_number] => 06417336 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-09 [patent_title] => 'Antibody against cleavage product or vimentin' [patent_app_type] => B1 [patent_app_number] => 09/610401 [patent_app_country] => US [patent_app_date] => 2000-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6016 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/417/06417336.pdf [firstpage_image] =>[orig_patent_app_number] => 09610401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 895703 [patent_doc_number] => 07342094 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-03-11 [patent_title] => 'Tumor vaccines for MUC1-positive carcinomas' [patent_app_type] => utility [patent_app_number] => 09/606910 [patent_app_country] => US [patent_app_date] => 2000-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 1305 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/342/07342094.pdf [firstpage_image] =>[orig_patent_app_number] => 09606910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1342370 [patent_doc_number] => 06590089 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-08 [patent_title] => 'RVP-1 variant differentially expressed in Crohn\'s disease' [patent_app_type] => B1 [patent_app_number] => 09/603552 [patent_app_country] => US [patent_app_date] => 2000-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18237 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/590/06590089.pdf [firstpage_image] =>[orig_patent_app_number] => 09603552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1286677 [patent_doc_number] => 06635421 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-21 [patent_title] => 'Neuropilins and use thereof in methods for diagnosis and prognosis of cancer' [patent_app_type] => B1 [patent_app_number] => 09/583638 [patent_app_country] => US [patent_app_date] => 2000-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 38 [patent_no_of_words] => 22426 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/635/06635421.pdf [firstpage_image] =>[orig_patent_app_number] => 09583638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1411142 [patent_doc_number] => 06517828 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-11 [patent_title] => 'C-CAM as an angiogenesis inhibitor' [patent_app_type] => B1 [patent_app_number] => 09/580043 [patent_app_country] => US [patent_app_date] => 2000-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 35922 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/517/06517828.pdf [firstpage_image] =>[orig_patent_app_number] => 09580043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1384796 [patent_doc_number] => 06548299 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-15 [patent_title] => 'Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices' [patent_app_type] => B1 [patent_app_number] => 09/574749 [patent_app_country] => US [patent_app_date] => 2000-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 6 [patent_no_of_words] => 21578 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/548/06548299.pdf [firstpage_image] =>[orig_patent_app_number] => 09574749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 668631 [patent_doc_number] => 07094873 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-08-22 [patent_title] => 'Polypeptide that interacts with heat shock proteins' [patent_app_type] => utility [patent_app_number] => 09/573473 [patent_app_country] => US [patent_app_date] => 2000-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 20784 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/094/07094873.pdf [firstpage_image] =>[orig_patent_app_number] => 09573473 [rel_patent_id] =>[rel_patent_doc_number] =>)